Molluscum Contagiosum - Penile Shaft Infection

Clinical Images

Clinical Features - Penile Shaft Specifics

• Smooth-surfaced, firm, dome-shaped pearly papule, 2-5 mm diameter
• Central umbilication (central pit/dimple) - pathognomonic feature
• Usually flesh-colored to pink; may become erythematous when inflamed
• Patients typically present with 1-30 lesions; usually asymptomatic

• Lower abdomen, upper thighs, perineum, penile shaft (most common male genital site)
• Pubic hair removal (shaving/waxing) is a risk factor for acquisition and spread
• Mucosal involvement is very uncommon

Key Differential Diagnoses

Diagnosis

Management of Genital Molluscum

• Physical destruction: Cryotherapy or curettage (most effective for genital lesions)
• Topical agents: 0.5% podophyllotoxin, 5% imiquimod (neither has strong RCT evidence for genital MC specifically), trichloroacetic acid (TCA)
• Counseling: Avoid shaving/waxing while active; do not share towels/bedding; advise sexual partners

Sources: Andrews' Diseases of the Skin, 13e, pp. 453-455 | Campbell-Walsh Wein Urology, p. 2687-2693

Treatment of Molluscum Contagiosum - Penile Shaft

First Decision: To Treat or Observe?

• Prevent autoinoculation and further spread
• Reduce sexual transmission to partners
• Address patient preference for faster resolution

Treatment Options - Evidence Ranked

Tier 1: Physical/Destructive Methods (First-Line for Genital MC)

• Preferred first-line for adult genital molluscum per Andrews' Diseases of the Skin
• Liquid nitrogen brief freeze of several seconds per lesion (30 sec-1 min with nitrous oxide probes); fine-tipped probes avoid freezing normal skin
• Repeat every 2-3 weeks if needed
• Network meta-analysis (25 RCTs, n=2,123) ranked cryotherapy second overall for complete clearance: OR 16.81 (95% CI 4.13-68.54) vs placebo (Chao et al., 2023 JDDG)
• Caution: Use with care in patients with darker skin tones - risk of post-inflammatory dyspigmentation
• Light cryotherapy also diagnostically useful - highlights the central umbilication

• Highly effective; often combined with or alternating with cryotherapy
• Requires topical/local anesthesia (EMLA 1 hour prior); small disposable sharp dermal curette
• Andrews': "removal by cryotherapy or curettage is very effective" for adult genital MC
• Penile skin is very thin - keep procedure superficial

Tier 2: Topical Chemical Agents

• OR 10.24 (95% CI 3.36-31.21) for complete clearance vs placebo - ranked 3rd in network meta-analysis
• Applied by patient twice daily for 3 days, repeated weekly for up to 4-6 weeks
• Contraindicated in pregnancy
• Note: Andrews' cautions that "neither imiquimod nor podophyllotoxin has been demonstrated to be effective" specifically for genital MC in controlled trials - clinical practice varies from meta-analysis results

• OR 10.02 (95% CI 4.64-21.64) - ranked 4th overall
• Applied topically once or twice daily until lesions resolve
• Mechanism: keratolytic disruption of molluscum bodies
• Generally well-tolerated; local irritation possible

• FDA-approved (2023) for MC in adults and children ≥2 years - newest approved agent
• Applied in-office every 21 days for up to 4 treatments
• Phase III RCTs (CAMP-1 & CAMP-2): complete clearance in 46-54% of treated patients vs 13-18% vehicle control (Gupta et al., 2023 - PMID 37945366)
• Mechanism: activates serine proteases → blistering → shedding of infected cells
• Caution on penile/perineal skin: Andrews' recommends avoiding cantharidin at the perineum due to risk of exuberant blistering on thin, sensitive skin. Apply with a wooden-tip cotton swab only to the lesion itself; wash off after 1-6 hours.

• Applied in-office to individual lesions
• Particularly useful in immunosuppressed patients
• Medium-depth peels (>35%) used for widespread lesions

• Commonly prescribed but evidence is weak
• Two large RCTs showed no benefit over placebo; Andrews' states clearly: "No controlled trials have confirmed the efficacy of imiquimod"
• Systematic review (Phan et al. 2021 - PMID 34920817) confirms "varying degrees of efficacy" - cannot be recommended as first-line
• Still used in some guidelines given safety profile and immune-modulating rationale

Tier 3: Other Reported Agents

Special Situations

HIV / Immunosuppressed Patients

• Start/optimize ART (HAART) first - most important intervention
• CD4 count inversely correlates with lesion burden; lesions resolve 6-8 months after ART initiation
• For few lesions: curettage or core removal
• For many/confluent lesions: TCA peels, daily 5-FU, topical cidofovir 1-3%
• Cryotherapy effective but risk dyspigmentation

Penile Shaft-Specific Cautions

• Penile skin is very thin - any procedure must be kept superficial to avoid scarring
• Avoid cantharidin + podophyllin mixtures on genital skin (unnecessarily caustic)
• EMLA (lidocaine/prilocaine) cream under occlusion 1 hour before curettage/cryotherapy improves tolerability - note risk of systemic toxicity with large surface area application

Prevention of Spread

• Avoid shaving/waxing the genital area while lesions are active (facilitates autoinoculation)
• Do not share towels, bed linen, or clothing with active lesions
• Advise sexual partners; screen for other STIs
• Condom use reduces (but does not eliminate) transmission

Summary: Practical Approach for Penile Shaft MC

Immunocompetent adult, few lesions (1-20):
→ Cryotherapy (LN₂) OR curettage = first-line
→ If patient prefers self-treatment: podophyllotoxin 0.5% or KOH 10%
→ In-office option: cantharidin 0.7% (YCANTH) - avoid heavy application on penile skin

Many lesions or treatment-resistant:
→ Combination: cryotherapy + podophyllotoxin
→ Refer dermatology; exclude HIV

HIV/immunosuppressed:
→ Optimize ART first
→ Curettage or TCA for individual lesions

Sources: Andrews' Diseases of the Skin, 13e, pp. 453-455 | Pfenninger & Fowler's Procedures for Primary Care, 3e | Campbell-Walsh Wein Urology | Chao et al., JDDG 2023 - Network Meta-Analysis, PMID 37199262 | Phan et al., Clin Dermatol 2021 - Systematic Review, PMID 34920817 | Gupta et al., Skinmed 2023 - Cantharidin Phase III RCT, PMID 37945366

Podophyllotoxin (Podofilox) - Complete Clinical Guide

What Is It?

Mechanism of Action

Indications

• External genital warts (condyloma acuminata) - HPV-6 and HPV-11
  • Penile shaft, vulvar, perianal external warts
  • Andrews' Dermatology explicitly recommends it for genital warts

• Molluscum contagiosum (penile shaft, genital region) - ranked 3rd for complete clearance in the 2023 network meta-analysis of 25 RCTs (OR 10.24, 95% CI 3.36-31.21 vs placebo; Chao et al., JDDG 2023)

• Cervical, vaginal, urethral meatal, or intra-anal warts (mucous membrane lesions - risk of excessive absorption)
• Warts with hair growth
• Bleeding warts, moles, or birthmarks
• Pregnancy (see below)

How to Use - Dosing Regimen

Standard Patient Self-Application Regimen (0.5% solution/gel):

• Apply twice daily (morning and evening) for 3 consecutive days
• Then 4 drug-free days (rest period)
• This constitutes one treatment cycle
• Repeat for up to 4 cycles (= 4 weeks total active treatment) until no visible wart tissue remains

1. Wash and dry the area thoroughly
2. Apply with the supplied applicator or a cotton swab only to the wart tissue - avoid surrounding healthy skin
3. Allow to dry before contact with clothing/partner
4. For penile warts: most men require less than 70 µL per application - at this dose, podofilox is NOT routinely detectable in serum (from Katzung's Basic & Clinical Pharmacology, 16e)
5. Optionally apply petrolatum (Vaseline) to surrounding healthy skin first to reduce irritation

• Podophyllin resin 10-25%: 30-60%
• Podophyllotoxin 0.5%: 45-75% (superior to crude podophyllin)

Comparison with Imiquimod

• No statistically significant difference in combined primary outcome (wart clearance at week 16 + wart-free at week 48)
• Adjusted OR for imiquimod vs podophyllotoxin = 0.81 (95% CI 0.54-1.23)
• Both agents performed comparably; podophyllotoxin had a shorter required treatment duration

Adverse Effects

• Burning, erythema, pain at application site - most common
• Skin erosion / ulceration if over-applied or applied to surrounding healthy skin
• Inflammation, itching
• The irritant reaction is variable between patients - test with 30-40 min exposure first, then extend to 1-4 hours on subsequent applications based on tolerance

• Nausea, vomiting
• Altered sensorium, confusion
• Peripheral neuropathy, diminished tendon reflexes
• Muscle weakness, ataxia
• Coma, death (with large-dose podophyllin misuse)
• At the standard ≤70 µL/application podofilox dose, serum levels are undetectable - systemic effects are not a practical concern

Contraindications

Important Notes for Penile Shaft Use

• The penile skin is thin - keep applications superficial and strictly confined to lesion tissue
• Protect surrounding healthy penile skin with petrolatum before applying
• Do not use cantharidin + podophyllin combinations on genital skin (unnecessarily caustic per Andrews')
• CDC guidance: Podophyllin resin (crude) is no longer recommended for external genital warts due to systemic toxicity risk; purified podophyllotoxin 0.5% is the preferred formulation
• For molluscum contagiosum specifically: Andrews' Diseases of the Skin notes "neither imiquimod nor podophyllotoxin has been demonstrated to be effective" in dedicated genital MC trials, despite network meta-analysis data - cryotherapy/curettage remain preferred for genital MC

Podophyllotoxin vs Podophyllin - Key Differences

Sources: Dermatology 2-Volume Set, 5e (Bolognia), pp. 4778-4793 | Katzung's Basic & Clinical Pharmacology, 16e, pp. 1824-1835 | Andrews' Diseases of the Skin, 13e | Gilson et al., HIPvac RCT, PMID 32975189 | Chao et al., Network Meta-Analysis, PMID 37199262